US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kestra Medical Technologies Inc

19.59

+0.49002.57%

Post-market: 18.22-1.3700-6.99%17:54 EDT

Volume:480.71K

Turnover:9.18M

Market Cap:1.14B

PE:-7.10

High:19.88

Open:19.52

Low:17.86

Close:19.10

52wk High:30.00

52wk Low:13.25

Shares:58.35M

Float Shares:30.74M

Volume Ratio:0.55

T/O Rate:1.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7601

EPS(LYR):-5.1308

ROE:-92.65%

ROA:-36.84%

PB:3.97

PE(LYR):-3.82

Loading ...

Overview Company News Filings

Kestra Medical CEO Brian Daniel Webster disposes of USD 304,124 in common shares

Kestra Medical Technologies (KMTS) Revenue Growth Versus Ongoing EPS Losses Tests Bullish Narratives

Simply Wall St.

Analysts Are Bullish on These Healthcare Stocks: Kestra Medical Technologies Ltd. (KMTS), NeuroPace (NPCE)

Kestra Medical Techs Price Target Maintained With a $32.00/Share by BTIG

Stock Track | Kestra Medical Technologies Plunges 5.11% After-Hours on Mixed Q3 Results with EPS and EBITDA Misses

Kestra Medical Technologies Ltd. publishes investor presentation on its ASSURE wearable defibrillator system and USD 10 billion U.S. market opportunity

Kestra Medical Techs Q3 EPS $(0.61) Misses $(0.59) Estimate, Sales $24.552M Beat $22.862M Estimate

BRIEF-Kestra Medical Technologies Inc Q3 EPS USD -0.61

Kestra Medical Technologies Inc Outlook FY Revenue USD 93 Million VS. Ibes Estimate USD 90.9 Million

THOMSON REUTERS

Press Release: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies Ltd expected to post a loss of 60 cents a share - Earnings Preview

Earning Preview: Kestra Medical Technologies Inc Q1 revenue is expected to increase by 10.43%, and institutional views are cautiously optimistic

Kestra Medical Technologies Ltd. Schedules Fiscal Q3 Earnings Release and Conference Call

Kestra Medical Technologies CEO Brian Daniel Webster Disposes of Common Shares

Kestra Medical Technologies Ltd. Officer Brian Daniel Webster Reports Sale of Common Shares

Kestra Medical Technologies Invests $5 Million in Biobeat Series B Round

Kestra Medical Technologies Ltd - Agreement Includes Exclusive License, $5 Mln Equity Investment in Biobeat's Series B

THOMSON REUTERS

Kestra Medical Technologies Announces Strategic Collaboration With Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery

THOMSON REUTERS

Kestra Medical price target raised to $27 from $25 at Goldman Sachs

Kestra Medical Technologies Officer Brian Daniel Webster Reports Disposal of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KMTS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KMTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KMTS\",,,,,undefined,":{"symbol":"KMTS","market":"US","secType":"STK","nameCN":"Kestra Medical Technologies Inc","latestPrice":19.59,"timestamp":1774296000000,"preClose":19.1,"halted":0,"volume":480708,"hourTrading":{"tag":"盘后","latestPrice":18.22,"preClose":19.59,"latestTime":"17:54 EDT","volume":6206,"amount":120823.51,"timestamp":1774302863277,"change":-1.37,"changeRate":-0.069934,"amplitude":0.069934},"delay":0,"changeRate":0.02565445026178002,"floatShares":30737300,"shares":58349053,"eps":-2.7601,"marketStatus":"Not Yet Opened","change":0.49,"latestTime":"03-23 16:00:00 EDT","open":19.52,"high":19.88,"low":17.86,"amount":9180508.025411999,"amplitude":0.105759,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.7601,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":0,"listingDate":1741237200000,"exchange":"NASDAQ","adjPreClose":19.1,"postHourTrading":{"tag":"盘后","latestPrice":18.22,"preClose":19.59,"latestTime":"17:54 EDT","volume":6206,"amount":120823.51,"timestamp":1774302863277,"change":-1.37,"changeRate":-0.069934,"amplitude":0.069934},"volumeRatio":0.552205},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KMTS\",,,,,undefined,":{"symbol":"KMTS","floatShares":30737300,"roa":"-36.84%","roe":"-92.65%","lyrEps":-5.130829,"volumeRatio":0.552205,"shares":58349053,"dividePrice":0,"high":19.88,"amplitude":0.105759,"preClose":19.1,"low":17.86,"week52Low":13.25,"pbRate":"3.97","psRate":"13.65","week52High":29.9999,"institutionHeld":0,"latestPrice":19.59,"eps":-2.7601,"divideRate":0,"volume":480708,"delay":0,"ttmEps":-2.7601,"open":19.52,"prevYearClose":26.52,"prevWeekClose":19.1,"prevMonthClose":23.28,"prevQuarterClose":26.52,"fiveDayClose":19.26,"twentyDayClose":26.69,"sixtyDayClose":27.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KMTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-17","symbol":"KMTS","fiscalQuarterEnding":"2026/01","expectedEps":-0.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"post","actualEps":-0.61},{"market":"US","date":"2025-12-11","symbol":"KMTS","fiscalQuarterEnding":"2025/10","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1765429200000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2025-09-11","symbol":"KMTS","fiscalQuarterEnding":"2025/07","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1757563200000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2025-07-15","symbol":"KMTS","fiscalQuarterEnding":"2025/04","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1752552000000,"reportTimeType":"post","actualEps":-2.09},{"date":"2025-04-14","symbol":"KMTS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1744660800000,"name":null,"time":"Post Market","dateTimestamp":1744603200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KMTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KMTS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.2857,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1764993600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KMTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KMTS","date":"2026-03-20","current":-7.097569,"percent":0.874525,"low":-16.18499,"twenty":-14.578157,"median":-12.075851,"eighty":-9.350663,"high":-6.523816,"avg":-11.923625,"sd":2.7296,"marketCap":1141782784},"quantilePoints":[{"date":"2025-03-07","current":-12.35476,"twenty":-12.554885,"median":-11.180499,"eighty":-10.006238,"marketCap":1039714860},{"date":"2025-03-14","current":-12.970055,"twenty":-12.629049,"median":-12.407735,"eighty":-11.210518,"marketCap":1091494957},{"date":"2025-03-21","current":-15.207953,"twenty":-14.317672,"median":-12.666719,"eighty":-12.218204,"marketCap":1279825304},{"date":"2025-03-28","current":-14.287183,"twenty":-14.764032,"median":-14.024977,"eighty":-12.386545,"marketCap":1202337886},{"date":"2025-04-04","current":-14.189618,"twenty":-15.037214,"median":-14.238401,"eighty":-12.435988,"marketCap":1194127299},{"date":"2025-04-11","current":-14.805497,"twenty":-14.959162,"median":-14.287183,"eighty":-12.468949,"marketCap":1245956631},{"date":"2025-04-17","current":-14.968672,"twenty":-14.980528,"median":-14.543291,"eighty":-12.629049,"marketCap":1258042072},{"date":"2025-04-25","current":-14.809821,"twenty":-14.980528,"median":-14.561947,"eighty":-12.901065,"marketCap":1244691421},{"date":"2025-05-02","current":-14.510448,"twenty":-14.980528,"median":-14.57378,"eighty":-13.099329,"marketCap":1219530580},{"date":"2025-05-09","current":-13.853659,"twenty":-14.968672,"median":-14.52687,"eighty":-13.313344,"marketCap":1164330774},{"date":"2025-05-16","current":-15.038934,"twenty":-14.968672,"median":-14.510448,"eighty":-13.429037,"marketCap":1263947167},{"date":"2025-05-23","current":-13.624547,"twenty":-14.968672,"median":-14.499429,"eighty":-13.584223,"marketCap":1145075028},{"date":"2025-05-30","current":-13.862824,"twenty":-14.962867,"median":-14.394364,"eighty":-13.570781,"marketCap":1165101004},{"date":"2025-06-06","current":-12.194886,"twenty":-14.925903,"median":-14.189618,"eighty":-13.303292,"marketCap":1024919173},{"date":"2025-06-13","current":-11.458671,"twenty":-14.858699,"median":-14.070552,"eighty":-12.688615,"marketCap":963044043},{"date":"2025-06-20","current":-9.473031,"twenty":-14.809821,"median":-14.026381,"eighty":-12.478367,"marketCap":796160911},{"date":"2025-06-27","current":-10.936295,"twenty":-14.809821,"median":-13.890825,"eighty":-12.194886,"marketCap":919140942},{"date":"2025-07-03","current":-9.573841,"twenty":-14.806362,"median":-13.853659,"eighty":-11.97616,"marketCap":804633439},{"date":"2025-07-11","current":-9.280577,"twenty":-14.766471,"median":-13.774234,"eighty":-10.800661,"marketCap":779986084},{"date":"2025-07-18","current":-7.426142,"twenty":-14.737973,"median":-13.685643,"eighty":-10.164034,"marketCap":845198877},{"date":"2025-07-25","current":-7.656235,"twenty":-14.706535,"median":-13.590943,"eighty":-9.755909,"marketCap":871386692},{"date":"2025-08-01","current":-7.444188,"twenty":-14.670521,"median":-13.343502,"eighty":-9.553679,"marketCap":847252824},{"date":"2025-08-08","current":-6.654653,"twenty":-14.650201,"median":-12.952105,"eighty":-9.265914,"marketCap":757392676},{"date":"2025-08-15","current":-7.20056,"twenty":-14.646954,"median":-12.647001,"eighty":-8.746062,"marketCap":819524549},{"date":"2025-08-22","current":-7.696839,"twenty":-14.588415,"median":-12.501587,"eighty":-7.538932,"marketCap":876008071},{"date":"2025-08-29","current":-7.990095,"twenty":-14.554847,"median":-12.407735,"eighty":-7.633677,"marketCap":909384697},{"date":"2025-09-05","current":-7.4487,"twenty":-14.54602,"median":-12.194886,"eighty":-7.513667,"marketCap":847766310},{"date":"2025-09-12","current":-8.301398,"twenty":-14.523585,"median":-12.003319,"eighty":-7.534421,"marketCap":944815270},{"date":"2025-09-19","current":-14.584722,"twenty":-14.523585,"median":-12.013371,"eighty":-7.608411,"marketCap":1296516135},{"date":"2025-09-26","current":-13.959662,"twenty":-14.54602,"median":-12.274823,"eighty":-7.65443,"marketCap":1240951158},{"date":"2025-10-03","current":-14.098564,"twenty":-14.523585,"median":-12.454823,"eighty":-7.664356,"marketCap":1253298931},{"date":"2025-10-10","current":-13.595044,"twenty":-14.510448,"median":-12.579795,"eighty":-7.67789,"marketCap":1208538254},{"date":"2025-10-17","current":-13.467717,"twenty":-14.497226,"median":-12.732694,"eighty":-7.691425,"marketCap":1197219463},{"date":"2025-10-24","current":-14.868314,"twenty":-14.54602,"median":-12.952105,"eighty":-7.872793,"marketCap":1321726171},{"date":"2025-10-31","current":-16.18499,"twenty":-14.646954,"median":-13.293239,"eighty":-7.992802,"marketCap":1438772767},{"date":"2025-11-07","current":-15.105605,"twenty":-14.742659,"median":-13.324583,"eighty":-8.032505,"marketCap":1342820283},{"date":"2025-11-14","current":-14.416882,"twenty":-14.807227,"median":-13.467717,"eighty":-8.060477,"marketCap":1281595910},{"date":"2025-11-21","current":-14.463182,"twenty":-14.809821,"median":-13.55734,"eighty":-8.097472,"marketCap":1285711834},{"date":"2025-11-28","current":-15.614912,"twenty":-14.869876,"median":-13.609796,"eighty":-8.15522,"marketCap":1388095449},{"date":"2025-12-05","current":-14.179591,"twenty":-14.886718,"median":-13.624547,"eighty":-8.244551,"marketCap":1260501798},{"date":"2025-12-12","current":-10.996761,"twenty":-14.869876,"median":-13.709795,"eighty":-8.325761,"marketCap":1453474910},{"date":"2025-12-19","current":-11.985631,"twenty":-14.859054,"median":-13.624547,"eighty":-8.369523,"marketCap":1584176788},{"date":"2025-12-26","current":-12.148971,"twenty":-14.838095,"median":-13.55734,"eighty":-8.506631,"marketCap":1605765938},{"date":"2026-01-02","current":-11.707511,"twenty":-14.809821,"median":-13.548744,"eighty":-9.011752,"marketCap":1547416885},{"date":"2026-01-09","current":-11.764901,"twenty":-14.809821,"median":-13.385353,"eighty":-9.109506,"marketCap":1555002262},{"date":"2026-01-16","current":-10.144744,"twenty":-14.805497,"median":-13.305665,"eighty":-9.182822,"marketCap":1340861237},{"date":"2026-01-23","current":-10.908469,"twenty":-14.790929,"median":-13.293239,"eighty":-9.202373,"marketCap":1441805099},{"date":"2026-01-30","current":-10.961444,"twenty":-14.762829,"median":-12.952105,"eighty":-9.265914,"marketCap":1448806985},{"date":"2026-02-06","current":-11.089468,"twenty":-14.737973,"median":-12.732694,"eighty":-9.344283,"marketCap":1465728211},{"date":"2026-02-13","current":-12.122483,"twenty":-14.706535,"median":-12.579795,"eighty":-9.404033,"marketCap":1602264995},{"date":"2026-02-20","current":-11.619219,"twenty":-14.677852,"median":-12.466595,"eighty":-9.422321,"marketCap":1535747074},{"date":"2026-02-27","current":-10.837836,"twenty":-14.653448,"median":-12.365286,"eighty":-9.454702,"marketCap":1432469251},{"date":"2026-03-06","current":-10.462595,"twenty":-14.646954,"median":-12.24477,"eighty":-9.533517,"marketCap":1382872556},{"date":"2026-03-13","current":-8.396564,"twenty":-14.609615,"median":-12.148971,"eighty":-9.533517,"marketCap":1109798988},{"date":"2026-03-20","current":-7.883607,"twenty":-14.578157,"median":-12.075851,"eighty":-9.350663,"marketCap":1141782784}],"updateTime":1774313817500},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KMTS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620827678","title":"Kestra Medical CEO Brian Daniel Webster disposes of USD 304,124 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620827678","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620827678?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:11","pubTimestamp":1773951068,"startTime":"0","endTime":"0","summary":"Brian Daniel Webster, President and Chief Executive Officer of Kestra Medical Technologies, reported selling 15,000 common shares on 03/17/2026.The sale was reported at a weighted average price of USD 20.27 per share.Following the transaction, Webster reported beneficial ownership of 364,786 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL5VZsbw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical CEO Brian Daniel Webster disposes of USD 304,124 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2620629503","title":"Kestra Medical Technologies (KMTS) Revenue Growth Versus Ongoing EPS Losses Tests Bullish Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2620629503","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620629503?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:11","pubTimestamp":1773871915,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies (KMTS) has just posted its latest quarterly update with Q2 2026 revenue of US$22.6 million and a basic EPS loss of US$0.64, alongside a trailing 12 month EPS loss of US$3.44 on revenue of US$74.3 million that highlights the current earnings profile. The company has seen quarterly revenue move from US$14.7 million in Q2 2025 to US$22.6 million in Q2 2026. Over the same period, quarterly basic EPS losses have shifted from US$1.19 in Q2 2025 to US$0.64 in Q2 2026,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-revenue-growth-versus-ongoi","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-revenue-growth-versus-ongoi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","BK4112","KMTS","BLSG","BLSX"],"gpt_icon":0},{"id":"2620210252","title":"Analysts Are Bullish on These Healthcare Stocks: Kestra Medical Technologies Ltd. (KMTS), NeuroPace (NPCE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620210252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620210252?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:30","pubTimestamp":1773844226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kestra Medical Technologies Ltd. (KMTS – Research Re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-kestra-medical-technologies-ltd-kmts-neuropace-npce-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-kestra-medical-technologies-ltd-kmts-neuropace-npce-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","BLSX","BK4082","KMTS","LU0029874061.USD","BK4588","NPCE","BLSG","BK4581","LABU","BK4539","XBI","LU0128526141.USD","BK4585","BK4137"],"gpt_icon":0},{"id":"2620723489","title":"Kestra Medical Techs Price Target Maintained With a $32.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2620723489","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620723489?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:06","pubTimestamp":1773828360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KMTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2026 06:06 ET (10:06 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"1134323014","title":"Stock Track | Kestra Medical Technologies Plunges 5.11% After-Hours on Mixed Q3 Results with EPS and EBITDA Misses","url":"https://stock-news.laohu8.com/highlight/detail?id=1134323014","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134323014?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:44","pubTimestamp":1773780279,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc's stock experienced a significant after-hours plunge of 5.11% following the release of its third-quarter fiscal 2026 financial results.The company reported a mixed...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KMTS"],"gpt_icon":0},{"id":"2620082424","title":"Kestra Medical Technologies Ltd. publishes investor presentation on its ASSURE wearable defibrillator system and USD 10 billion U.S. market opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2620082424","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620082424?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:17","pubTimestamp":1773778672,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Ltd. publishes investor presentation on its ASSURE wearable defibrillator system and USD 10 billion U.S. market opportunity. Kestra said it is focused on at-home cardiac care for patients at elevated risk of sudden cardiac arrest, centered on its Cardiac Recovery System anchored by the ASSURE wearable cardioverter defibrillator. The company reported 33,000+ patients protected and 290 million+ covered lives. Kestra also cited a 1-year appropriate therapy rate of 5.4% during the ICD waiting period, and said 73% of sudden cardiac arrests occur at home or a residence. The presentation described a USD 10 billion U.S. total addressable market estimate, including an existing USD 1 billion+ wearable cardioverter defibrillator market. Kestra reported revenue of USD 93 million for FY25 and issued FY26 revenue guidance of USD 59.8 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to prov","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL7PsLmL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2620083344","title":"Kestra Medical Techs Q3 EPS $(0.61) Misses $(0.59) Estimate, Sales $24.552M Beat $22.862M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2620083344","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620083344?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:01","pubTimestamp":1773777719,"startTime":"0","endTime":"0","summary":"Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.59) by 2.52 percent. This is a 51.2 percent increase over losses of $(1.25) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51310150/kestra-medical-techs-q3-eps-0-61-misses-0-59-estimate-sales-24-552m-beat-22-862m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical Techs Q3 EPS $(0.61) Misses $(0.59) Estimate, Sales $24.552M Beat $22.862M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2620408388","title":"BRIEF-Kestra Medical Technologies Inc Q3 EPS USD -0.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2620408388","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620408388?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:01","pubTimestamp":1773777705,"startTime":"0","endTime":"0","summary":"Mar 17  - Kestra Medical Technologies Inc Q3 adjusted EBITDA USD -21.191 million vs. IBES estimate USD -20.7 million.outlook FY revenue USD 93 million vs. IBES estimate USD 90.9 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nPLXD86622:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2620005470","title":"Kestra Medical Technologies Inc Outlook FY Revenue USD 93 Million VS. Ibes Estimate USD 90.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620005470","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620005470?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:01","pubTimestamp":1773777660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nPLXD86622:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2620140884","title":"Press Release: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620140884","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620140884?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:01","pubTimestamp":1773777660,"startTime":"0","endTime":"0","summary":"KIRKLAND, Wash., March 17, 2026  -- Kestra Medical Technologies, Ltd. , a leading wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026.-- Generated revenue of $24.6 million in Q3 FY26, an increase of 63%. -- Expanded gross margin to 52.6% in Q3 FY26 compared to 43.4% in the prior. -- Increased FY26 revenue guidance to $93 million, representing growth of. \"Kestra delivered another strong quarter of financial performance, generating revenue growth of 63% while expanding gross margin to over 52%,\" said Brian Webster, President and CEO. \"We also continued to execute on several key operational objectives, including rapid growth of the commercial organization, release of compelling primary results from our FDA post-approval study, fortification of our balance sheet with an equity offering, and entrance into a strategic collaboration with Biobeat Technologies. As we progress on our journey to c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082","BK4022","BK4232","R"],"gpt_icon":0},{"id":"2619414827","title":"Kestra Medical Technologies Ltd  expected to post a loss of 60 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2619414827","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619414827?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:54","pubTimestamp":1773435251,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Ltd  expected to post a loss of60cents a share - Earnings Preview Kestra Medical Technologies Ltd KMTS.OQ KMTS.O is expected to  report resultson March 17 for the period en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL8N401235:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"1170624879","title":"Earning Preview: Kestra Medical Technologies Inc Q1 revenue is expected to increase by 10.43%, and institutional views are cautiously optimistic","url":"https://stock-news.laohu8.com/highlight/detail?id=1170624879","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170624879?lang=en_us&edition=fundamental","pubTime":"2026-03-10 11:19","pubTimestamp":1773112745,"startTime":"0","endTime":"0","summary":"Abstract Kestra Medical Technologies Inc will report fiscal results on March 17, 2026 Post Market; this preview compiles the latest quarterly actuals and current-quarter forecasts, highlighting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Kestra Medical Technologies Inc Q1 revenue is expected to increase by 10.43%, and institutional views are cautiously optimistic","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS"],"gpt_icon":0},{"id":"2616349642","title":"Kestra Medical Technologies Ltd. Schedules Fiscal Q3 Earnings Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2616349642","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616349642?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:00","pubTimestamp":1772535621,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Ltd. will report its third quarter fiscal 2026 financial results on March 17, 2026. Management will host a conference call the same day at 4:30 p.m. Eastern Time, with a live and archived webcast available in the “Events” section of the investor relations website.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDLc4r5gw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","KMTS","NDAQ","LU2095319765.USD","BK4082","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014005.SGD","BK4112","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2612235901","title":"Kestra Medical Technologies CEO Brian Daniel Webster Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612235901","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612235901?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:35","pubTimestamp":1771536950,"startTime":"0","endTime":"0","summary":"Brian Daniel Webster, President and Chief Executive Officer, reported a disposal of common shares of Kestra Medical Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL1jdqc1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical Technologies CEO Brian Daniel Webster Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2604272194","title":"Kestra Medical Technologies Ltd. Officer Brian Daniel Webster Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2604272194","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604272194?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:04","pubTimestamp":1768907076,"startTime":"0","endTime":"0","summary":"Brian Daniel Webster, Director and Officer of Kestra Medical Technologies Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL31d7Bw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical Technologies Ltd. Officer Brian Daniel Webster Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2603688491","title":"Kestra Medical Technologies Invests $5 Million in Biobeat Series B Round","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688491","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603688491?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:00","pubTimestamp":1768302039,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Ltd. has entered into a strategic collaboration with Biobeat Technologies Ltd., which includes a $5 million equity investment in Biobeat's recently announced Series B financing. As part of the agreement, Kestra has secured an exclusive license and co-development arrangement with Biobeat to enhance diagnostic insights for patients prescribed the ASSURE Wearable Cardioverter Defibrillator.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLbBH6CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","BK4585","BK4082","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU0314104364.USD","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD","SG9999014013.SGD","SG9999014039.USD","IE00B64PRP62.GBP","KMTS","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2603688479","title":"Kestra Medical Technologies Ltd - Agreement Includes Exclusive License, $5 Mln Equity Investment in Biobeat's Series B","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603688479?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:00","pubTimestamp":1768302028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0JN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2603688231","title":"Kestra Medical Technologies Announces Strategic Collaboration With Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603688231?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:00","pubTimestamp":1768302028,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2602043322","title":"Kestra Medical price target raised to $27 from $25 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2602043322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602043322?lang=en_us&edition=fundamental","pubTime":"2026-01-09 18:56","pubTimestamp":1767956170,"startTime":"0","endTime":"0","summary":"Goldman Sachs raised the firm’s price target on Kestra Medical (KMTS) to $27 from $25 and keeps a Neutral rating on the shares. After a year when f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kestra-medical-price-target-raised-to-27-from-25-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kestra-medical-price-target-raised-to-27-from-25-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096364046.USD","LU0345770993.USD","IE00BSNM7G36.USD","IE0002270589.USD","KMTS","LU2237443465.HKD","LU2750360641.GBP","LU0048573561.USD","IE00B19Z3581.USD","BK4082","LU0345770308.USD","LU2471134523.USD","LU2237443549.SGD","LU2237443382.USD","BK4588","LU2471134952.CNY","BK4127","IE0004091025.USD","LU0742534661.SGD","LU0251142724.SGD","LU1868836914.USD","BK4585","LU1791807156.HKD","LU1804176565.USD","LU2237438978.USD","BK4552","IE0034235188.USD","IE0004086264.USD","LU1668664300.SGD","LU1868836591.USD","LU2237443978.SGD","LU1868837300.USD","LU1894683264.USD","LU2471134796.USD","BK4550","BK4533","BK4504","LU0106831901.USD","IE00BFXG1179.USD","LU0251131958.USD","LU1868836757.USD","LU2750360997.AUD","LU2237443895.HKD","IE00B19Z3B42.SGD","BK4516","LU1868837136.USD","LU2237443622.USD","LU0061475181.USD","LU2265009873.SGD"],"gpt_icon":0},{"id":"2600701367","title":"Kestra Medical Technologies Officer Brian Daniel Webster Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2600701367","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600701367?lang=en_us&edition=fundamental","pubTime":"2026-01-01 05:15","pubTimestamp":1767215713,"startTime":"0","endTime":"0","summary":"Brian Daniel Webster, Director and Officer of Kestra Medical Technologies Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 31, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL9R3CkC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical Technologies Officer Brian Daniel Webster Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}]}}